Jon Owen Nagy

Principal investigator.

Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$6.4MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20162025
AwardsPatents
Federal awards as principal investigator

9 awards · $6.4M

DateAgencyAwardAmountCompany
May 1, 2025NIHSTTR Phase II
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
$1.0MNANOVALENT PHARMACEUTICALS INC
Jul 29, 2024NIHSTTR Phase II
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
$1.0MNANOVALENT PHARMACEUTICALS INC
Aug 8, 2023NIHSTTR Phase II
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
$400KNANOVALENT PHARMACEUTICALS INC
Apr 2, 2020NIHSBIR Phase II
NV103: Antibody Conjugated Nanoparticle for Ewing Sarcoma Targeted Therapy
$893KNANOVALENT PHARMACEUTICALS INC
Aug 28, 2019NIHSBIR Phase II
Targeted Polymerized Shell Microbubbles to Image and Treat Surgical Adhesions
$759KNANOVALENT PHARMACEUTICALS INC
Apr 19, 2019NIHSBIR Phase II
NV103: Antibody Conjugated Nanoparticle for Ewing Sarcoma Targeted Therapy
$1.0MNANOVALENT PHARMACEUTICALS INC
Sep 14, 2018NIHSBIR Phase II
NV103: Antibody Conjugated Nanoparticle for Ewing Sarcoma Targeted Therapy
$241KNANOVALENT PHARMACEUTICALS INC
Aug 29, 2018NIHSBIR Phase II
Targeted Polymerized Shell Microbubbles to Image and Treat Surgical Adhesions
$831KNANOVALENT PHARMACEUTICALS INC
Apr 15, 2016NIHSTTR Phase I
Nanoparticle Delivery System for Ewing Sarcoma Treatment
$241KNANOVALENT PHARMACEUTICALS INC
Among 4,078 researchers in Biotech

Peer ranks

Federal funding#164
Awards as PI#151
Patents#273
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.